Insider Trading History of Chiniara Ellen

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Chiniara Ellen since 2015. This trader's CIK number is 1398764. At the time of last reporting, Chiniara Ellen was the Chief Legal Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR). Also see all insider trading activities at Kymera Therapeutics, Inc..

Note that in the past Chiniara Ellen also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Kymera Therapeutics, Inc. (KYMR) by Chiniara Ellen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 KYMR 0 $0 5,370 $199,367 0 $0
2024 KYMR 0 $0 3,295 $74,414 0 $0

Yearly summary of insider trading at Inverness Medical Innovations Inc (ALR) by Chiniara Ellen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 ALR 0 $0 0 $0 16,403 $0
2016 ALR 0 $0 0 $0 31,667 $943,500
2015 ALR 0 $0 0 $0 6,666 $0


Insider trading activities at 2 companies by Chiniara Ellen:

1. Kymera Therapeutics, Inc. (KYMR)

2. Inverness Medical Innovations Inc (ALR)

Table 1. Insider trading of Kymera Therapeutics, Inc. (KYMR) by Chiniara Ellen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-03 KYMR Sale 2,241 30.67 68,722
2025-01-06 KYMR Sale 3,129 41.75 130,645
2024-01-04 KYMR Sale 3,295 22.58 74,414

Table 2. Insider trading of Inverness Medical Innovations Inc (ALR) by Chiniara Ellen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-08-31 ALR Option Ex 6,667 .00 0
2017-02-16 ALR Option Ex 9,736 .00 0
2016-10-14 ALR Option Ex 25,000 37.74 943,500
2016-09-09 ALR Option Ex 6,667 .00 0
2015-08-31 ALR Option Ex 6,666 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chiniara Ellen (Chief Legal Officer of Kymera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.